Related Experiment Videos
Renal subcapsular islet cell transplantation
Diabetes
|September 1, 1984
Summary
Renal subcapsular islet cell transplantation in dogs shows promise for treating diabetes. This method achieved normoglycemia and prolonged graft survival, suggesting potential for human application.
Area of Science:
- Transplantation immunology
- Endocrinology
- Surgical innovation
Background:
- Islet cell transplantation is a potential treatment for diabetes.
- Graft rejection remains a significant challenge in islet cell transplantation.
Purpose of the Study:
- To investigate the renal subcapsular region as a novel site for canine islet cell allografts.
- To evaluate the efficacy of a noncollagenase mechanical preparation technique for islet allografts.
Main Methods:
- Canine pancreatectomy followed by islet cell allograft transplantation to the renal subcapsular site.
- Comparison of outcomes with and without immunosuppression (azathioprine).
- Assessment of graft function via nephrectomy to induce hyperglycemia.
Main Results:
- Normoglycemia and excellent survival (>60 days) were achieved in pancreatectomized dogs receiving renal subcapsular islet allografts.
- Graft dependence was confirmed by nephrectomy leading to hyperglycemia and death.
- Prolonged normoglycemia (>4-6 months) was observed in some recipients, even with minimal or no immunosuppression.
Conclusions:
- The renal subcapsular site is a viable and effective location for canine islet cell allografts.
- This technique, combined with a noncollagenase preparation method, offers a promising approach to islet cell transplantation.
- Further research is warranted to explore the mechanisms behind prolonged allograft survival and its potential application in humans.